Literature DB >> 30607772

Congenital Adrenal Hyperplasia and Growth Outcomes.

Rajni Sharma1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30607772     DOI： 10.1007/s12098-018-2841-7

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  11 in total

Review 1.  Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis.

Authors:  Kalpana Muthusamy; Mohamed B Elamin; Galina Smushkin; Mohammad Hassan Murad; Julianna F Lampropulos; Khalid B Elamin; Nisrin O Abu Elnour; Juan F Gallegos-Orozco; Mitra M Fatourechi; Neera Agrwal; Melanie A Lane; Felipe N Albuquerque; Patricia J Erwin; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2010-09       Impact factor: 5.958

2.  Long-term Growth in Congenital Adrenal Hyperplasia.

Authors:  Ankita Maheshwari; Vaman Khadilkar; Priyanka Gangodkar; Anuradha Khadilkar
Journal:  Indian J Pediatr       Date:  2018-08-10       Impact factor: 1.967

Review 3.  Growth and development in children with classic congenital adrenal hyperplasia.

Authors:  Walter Bonfig
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-02       Impact factor: 3.243

Review 4.  Congenital adrenal hyperplasia: issues in diagnosis and treatment in children.

Authors:  Rajni Sharma; Anju Seth
Journal:  Indian J Pediatr       Date:  2013-11-20       Impact factor: 1.967

5.  Final adult height in children with congenital adrenal hyperplasia treated with growth hormone.

Authors:  Karen Lin-Su; Madeleine D Harbison; Oksana Lekarev; Maria G Vogiatzi; Maria I New
Journal:  J Clin Endocrinol Metab       Date:  2011-03-30       Impact factor: 5.958

6.  Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth.

Authors:  S A Rivkees; J D Crawford
Journal:  Pediatrics       Date:  2000-10       Impact factor: 7.124

7.  Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.

Authors:  Walter Bonfig; Susanne Bechtold Dalla Pozza; Heinrich Schmidt; Philipp Pagel; Dietrich Knorr; Hans Peter Schwarz
Journal:  J Clin Endocrinol Metab       Date:  2009-07-21       Impact factor: 5.958

8.  CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency.

Authors:  Antonio Balsamo; Alessandro Cicognani; Lilia Baldazzi; Michela Barbaro; Federico Baronio; Monia Gennari; Milva Bal; Alessandra Cassio; Krissi Kontaxaki; Emanuele Cacciari
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

9.  Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Phyllis W Speiser; Wiebke Arlt; Richard J Auchus; Laurence S Baskin; Gerard S Conway; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; M Hassan Murad; Sharon E Oberfield; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

10.  A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia.

Authors:  Somya Verma; Carol Vanryzin; Ninet Sinaii; Mimi S Kim; Lynnette K Nieman; Shayna Ravindran; Karim A Calis; Wiebke Arlt; Richard J Ross; Deborah P Merke
Journal:  Clin Endocrinol (Oxf)       Date:  2009-05-25       Impact factor: 3.478
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.